Clinical trial
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
NCT00003867
Study timeline
Study start (actual)1999-03-01Date precision: month
Registry last updated2018-09-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancerunresolved
Interventions
capecitabineDRUG · verified · RxNorm: capecitabine
irinotecan hydrochlorideDRUG · verified · RxNorm: irinotecan hydrochloride
Sponsors & collaborators
Montefiore Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003867 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.